Neogenomics Inc - ESG Rating & Company Profile powered by AI
This webpage is a zero-cost Environmental, Social and Governance report covering Neogenomics Inc. This analysis of Neogenomics Inc employs data points from across the internet and also from available filings by Neogenomics Inc. Alternative corporations in the rating peer group for Neogenomics Inc are displayedin the table.
Neogenomics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.4; made up of an environmental score of 5.3, social score of 5.7 and governance score of 5.3.
5.4
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 627 | Ultimovacs ASA | 5.5 | High |
| 627 | United Therapeutics Corp | 5.5 | High |
| 645 | Neogenomics Inc | 5.4 | High |
| 645 | Candel Therapeutics Inc | 5.4 | High |
| 645 | Eiger BioPharmaceuticals Inc | 5.4 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Neogenomics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Neogenomics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Neogenomics Inc report the average age of the workforce?
Sign up for free to unlockDoes Neogenomics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Neogenomics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Neogenomics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Neogenomics Inc offer flexible work?
Sign up for free to unlockDoes Neogenomics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Neogenomics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Neogenomics Inc conduct supply chain audits?
Sign up for free to unlockDoes Neogenomics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Neogenomics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Neogenomics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Neogenomics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Neogenomics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Neogenomics Inc disclose water use targets?
Sign up for free to unlockDoes Neogenomics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Neogenomics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Neogenomics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Neogenomics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Neogenomics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Neogenomics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Neogenomics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Neogenomics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Neogenomics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Neogenomics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Neogenomics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Neogenomics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Neogenomics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Neogenomics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Neogenomics Inc disclose its waste policy?
Sign up for free to unlockDoes Neogenomics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Neogenomics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Neogenomics Inc disclose energy use targets?
Sign up for free to unlockDoes Neogenomics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Neogenomics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Neogenomics Inc
These potential risks are based on the size, segment and geographies of the company.
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. The company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization, as well as acts as a reference laboratory supplying anatomic pathology testing services. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited. The company was founded in 2001 and is headquartered in Fort Myers, Florida.